🇺🇸 FDA
Patent

US 8404849

Processes for producing modulators of cystic fibrosis transmembrane conductance regulator

granted A61PA61P11/00A61P43/00

Quick answer

US patent 8404849 (Processes for producing modulators of cystic fibrosis transmembrane conductance regulator) held by Vertex Pharmaceuticals Incorporated expires Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Mar 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61P, A61P11/00, A61P43/00